![]() |
市場調查報告書
商品編碼
2068768
醫療保健供應鏈管理市場預測至2034年—按組件、功能、技術、交付模式、應用、最終用戶和地區分類的全球分析Healthcare Supply Chain Management Market Forecasts to 2034 - Global Analysis By Component (Software and Services), Function, Technology, Delivery Model, Application, End User and By Geography |
||||||
根據 Stratistics MRC 的數據,全球醫療保健供應鏈管理市場預計將在 2026 年達到 62 億美元,到 2034 年達到 148 億美元,在預測期內以 11.4% 的複合年成長率成長。
醫療供應鏈管理 (HSCM) 涵蓋整個醫療生態系統中藥品、醫療設備和臨床用品的採購、庫存管理、物流和配送的端到端協調。它整合了先進的軟體平台和即時數據分析,以確保產品從製造商到患者的無縫流動,同時減少浪費、最大限度地減少缺貨,並確保符合監管要求。
醫療服務領域對營運效率和成本降低的需求日益成長。
醫療機構面臨越來越大的財務壓力,需要在不影響患者療效的前提下降低營運成本。供應鏈管理解決方案能夠幫助醫療機構最佳化採購週期、減少庫存積壓並實現工作流程自動化。透過實施先進的分析技術和人工智慧驅動的需求預測,醫院和經銷商可以預測需求波動、預防藥品短缺並降低庫存持有成本。這種從被動應對向主動預防的供應鏈策略轉變正在加速普及,尤其是在大規模醫療系統中,這些系統致力於消除地理位置分散的機構之間存在的系統性效率低下問題。
IT基礎設施分散化與互通性挑戰
阻礙廣泛應用的主要障礙之一是缺乏標準化的資料格式以及不同醫院資訊系統、ERP平台和供應商網路之間的無縫整合。許多醫療機構仍在運行與現代HSCM解決方案不相容的舊有系統,需要耗費大量成本和時間進行升級。此外,不同司法管轄區的法規結構差異也使跨境供應鏈的可視性變得複雜。這些互通性差距阻礙了即時數據共用,限制了端到端的可追溯性,增加了用藥錯誤的風險,並最終減緩了數位化供應鏈轉型的步伐。
人工智慧驅動的需求預測和基於區塊鏈的擴展可追溯性
人工智慧與區塊鏈技術的融合為變革醫療供應鏈提供了契機。人工智慧驅動的預測模型能夠分析過往的消費模式、季節性疾病趨勢以及採購數據,從而產生精準的需求預測,最大限度地減少庫存積壓和缺貨情況。同時,區塊鏈平台提供防篡改的交易記錄,提升從生產商到患者的產品可追溯性,幫助打擊假藥並確保低溫運輸合規。隨著監管機構對藥品供應鏈透明度的要求日益提高,提供人工智慧和區塊鏈整合供應鏈解決方案的供應商有望佔據可觀的市場佔有率。
地緣政治不穩定和對單一供應來源的依賴
由於地緣政治不穩定、貿易限制以及對特定來源的依賴,全球醫療保健供應鏈仍然極其脆弱,尤其是活性藥物成分主要來自少數國家。出口禁令、港口擁擠或原料短缺造成的供應鏈中斷會迅速波及整個供應鏈網路,可能導致嚴重的藥品短缺和患者照護延誤。新冠疫情暴露了這些結構性脆弱性,促使醫療系統和各國政府重新評估其供應鏈的韌性。然而,實現供應商多元化和建立區域儲備系統需要大量的投資和複雜的運作。
新冠疫情對醫療供應鏈造成了巨大衝擊,暴露了庫存可視性、需求預測和供應商多元化的重大缺陷。個人防護工具(PPE)、人工呼吸器和疫苗的需求激增至前所未有的水平,現有分銷網路不堪重負,導致大規模短缺。為應對這一局面,醫療系統加快了數位轉型步伐,部署了即時追蹤平台和人工智慧驅動的需求預測工具,以應對供應波動。這場危機促使各方對供應鏈韌性和高階分析技術進行長期投資,隨著各機構優先考慮營運彈性和端到端可追溯性,市場也為疫情後的強勁成長奠定了基礎。
在預測期內,軟體領域預計將佔據最大佔有率。
在預測期內,軟體領域預計將佔據最大的市場佔有率,這主要得益於庫存管理平台、ERP整合採購解決方案和需求預測工具的普及。醫療機構高度依賴軟體來實現手動工作流程的數位化、確保合規性,並實現對其多層供應鏈網路的即時可視性。此外,對雲端部署的日益青睞也進一步推動了軟體領域的擴張,使得不同規模的醫院都能以經濟高效的方式快速擴充性和使用軟體。
預計在預測期內,採購管理細分市場將呈現最高的複合年成長率。
在預測期內,採購管理領域預計將呈現最高的成長率,這主要得益於降低營運成本、提高庫存可視性和及時取得醫療用品的需求不斷成長。醫療機構正在採用數位化採購平台、自動化和數據分析來簡化採購流程並加強與供應商的合作。此外,對以價值為導向的醫療保健的日益重視以及對最大限度減少供應中斷的關注,也加速了醫療機構對採購管理的採用。
在預測期內,北美預計將佔據最大的市場佔有率,這主要得益於其成熟的醫療保健基礎設施、較高的技術普及率以及對供應鏈透明度要求嚴格的法規環境。尤其是在美國,大規模醫院網路早期採用ERP和WMS平台,以及持續履行《藥品供應鏈安全法案》(DSCSA)規定的合規義務,將為北美市場的發展提供強勁動力。此外,麥克森(McKesson)和康德樂(Cardinal Health)等主要供應商以及資金雄厚的醫療用品批發商的存在,進一步鞏固了該地區的市場主導地位。
在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於醫療基礎設施的快速擴張、藥品生產活動的活性化以及政府主導的醫院供應鏈現代化舉措的推進。中國、印度和韓國等國家正在大力投資數位醫療平台和低溫運輸物流,以支持其快速成長的藥品出口產業和龐大的國內患者群體。低成本雲端解決方案的普及也使該地區的小規模醫療機構能夠大規模部署醫療供應鏈管理(HSCM)工具。
According to Stratistics MRC, the Global Healthcare Supply Chain Management Market is accounted for $6.2 billion in 2026 and is expected to reach $14.8 billion by 2034, growing at a CAGR of 11.4% during the forecast period. Healthcare Supply Chain Management (HSCM) encompasses the end-to-end coordination of procurement, inventory, logistics, and distribution of pharmaceutical products, medical devices, and clinical supplies across the healthcare ecosystem. It integrates advanced software platforms with real-time data analytics to ensure uninterrupted product flow from manufacturers to patients, reducing waste, minimizing stockouts, and maintaining compliance with regulatory mandates.
Rising demand for operational efficiency and cost containment in healthcare delivery
Healthcare organizations are under mounting financial pressure to curtail operational expenditures without compromising patient outcomes. Supply chain management solutions enable institutions to optimize procurement cycles, reduce excess inventory, and automate manual workflows. By deploying advanced analytics and AI-driven forecasting, hospitals and distributors can anticipate demand fluctuations, prevent drug shortages, and lower carrying costs. This transition from reactive to proactive supply chain strategies is accelerating adoption, particularly among large health systems seeking to eliminate systemic inefficiencies across geographically dispersed facilities.
Fragmented IT infrastructure and interoperability challenges
A significant barrier to widespread adoption is the lack of standardized data formats and seamless integration across disparate hospital information systems, ERP platforms, and supplier networks. Many healthcare institutions operate legacy systems that are incompatible with modern HSCM solutions, requiring costly and time-intensive upgrades. Additionally, variations in regulatory frameworks across jurisdictions complicate cross-border supply chain visibility. These interoperability gaps hinder real-time data sharing, limit end-to-end traceability, and increase the risk of medication errors, ultimately slowing the pace of digital supply chain transformation.
Expansion of AI-driven demand forecasting and blockchain-enabled traceability
The convergence of artificial intelligence and blockchain technology presents a transformative opportunity for healthcare supply chains. AI-powered predictive models can analyze historical consumption patterns, seasonal disease trends, and procurement data to generate precise demand forecasts, minimizing both overstock and shortages. Simultaneously, blockchain platforms offer immutable transaction records that enhance product traceability from manufacturer to patient, combating counterfeit drugs and ensuring cold-chain compliance. As regulatory bodies mandate greater drug supply transparency, vendors offering integrated AI-blockchain supply chain solutions stand to capture substantial market share.
Geopolitical disruptions and single-source supplier dependency
Global healthcare supply chains remain acutely vulnerable to geopolitical instability, trade restrictions, and concentrated supplier dependencies, particularly for active pharmaceutical ingredients sourced from a limited number of countries. Disruptions arising from export bans, port congestion, or raw material shortages can cascade rapidly through supply networks, leading to critical drug shortages and patient care delays. The COVID-19 pandemic exposed these structural vulnerabilities, prompting health systems and governments to reassess supply chain resilience. However, diversifying supplier bases and building regional stockpiles entail substantial investment and operational complexity.
The COVID-19 pandemic profoundly disrupted healthcare supply chains, exposing critical gaps in inventory visibility, demand forecasting, and supplier diversification. Unprecedented surges in demand for PPE, ventilators, and vaccines overwhelmed existing distribution networks, triggering widespread shortages. In response, health systems accelerated digital transformation initiatives, deploying real-time tracking platforms and AI-driven forecasting tools to navigate supply volatility. The crisis catalyzed long-term investment in supply chain resilience and advanced analytics, positioning the market for robust post-pandemic growth as institutions prioritize operational agility and end-to-end traceability.
The software segment is expected to be the largest during the forecast period
The software segment is expected to account for the largest market share during the forecast period, driven by widespread adoption of inventory management platforms, ERP-integrated procurement solutions, and demand forecasting tools. Healthcare organizations rely heavily on software to digitize manual workflows, ensure regulatory compliance, and achieve real-time visibility across multi-tiered supply networks. The growing preference for cloud-based deployment has further expanded the software segment, enabling rapid scalability and cost-effective access across hospitals of varying sizes.
The procurement management segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the procurement management segment is predicted to witness the highest growth rate, driven by the increasing need to reduce operational costs, improve inventory visibility, and ensure timely availability of medical supplies. Healthcare organizations are adopting digital procurement platforms, automation, and data analytics to streamline purchasing processes and enhance supplier collaboration. Additionally, the growing focus on value-based healthcare and minimizing supply disruptions is accelerating procurement management adoption across healthcare facilities.
During the forecast period, the North America region is expected to hold the largest market share, driven by a mature healthcare infrastructure, high technology adoption rates, and a stringent regulatory environment demanding supply chain transparency. The United States, in particular, benefits from early adoption of ERP and WMS platforms among large hospital networks, alongside ongoing compliance obligations under the DSCSA. The presence of leading software vendors and well-capitalized healthcare distributors such as McKesson and Cardinal Health further reinforces the region's market dominance.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by rapid healthcare infrastructure expansion, rising pharmaceutical manufacturing activity, and growing government initiatives to modernize hospital supply chains. Countries such as China, India, and South Korea are investing heavily in digital health platforms and cold-chain logistics to support their burgeoning pharmaceutical export industries and large domestic patient populations. The proliferation of low-cost cloud-based solutions is also enabling smaller healthcare providers in the region to adopt HSCM tools at scale.
Key players in the market
Some of the key players in Healthcare Supply Chain Management Market include SAP SE, Oracle Corporation, McKesson Corporation, Cardinal Health, Inc., Cencora, Inc., Global Healthcare Exchange (GHX), Infor Inc., Tecsys Inc., Manhattan Associates, Inc., Blue Yonder Group, Inc., Kinaxis Inc., Epicor Software Corporation, Avery Dennison Corporation, Medline Industries, LP, Premier, Inc.
In March 2026, McKesson Corporation announced the expansion of its CoverMyMeds platform to include AI-driven prior authorization automation capabilities, enabling healthcare providers to expedite medication access for patients and reduce administrative burden across pharmacy benefit networks.
In February 2026, SAP SE unveiled an enhanced version of its SAP Intelligent Asset Management solution integrated with generative AI capabilities, enabling pharmaceutical companies to predict equipment failures and optimize maintenance schedules within their manufacturing and supply chain operations.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.